SOUTH SAN FRANCISCO, Calif. & SUNNYVALE, Calif.--(BUSINESS WIRE)--Fluidigm Corp. (NASDAQ: FLDM) today announced it has completed its acquisition of DVS Sciences, Inc. With the closing of the acquisition, Fluidigm adds a high-parameter single-cell protein analysis platform to its industry-leading single-cell genomics platforms to create a comprehensive portfolio of advanced technologies serving the rapidly growing single-cell genomics and proteomics markets.
Help employers find you! Check out all the jobs and post your resume.
